Table 2 Professional participants’ change in knowledge of medications for substance use disorders and confidence in skills treating patients with substance use disorders before and after the ECHO program (overall average scores across six cohorts)
N | Pre-program mean* (SD) | Percentage agree/strongly agree | Post-program mean* (SD) | Percentage agree/strongly agree | p value*** | |
|---|---|---|---|---|---|---|
Statement: I am knowledgeable about the following medications: | ||||||
Buprenorphine | 73 | 3.15 (1.11) | 42.7 | 4.08 (0.83) | 82.3 | < 0.001 |
Combination of buprenorphine and naloxone | 73 | 2.81 (1.05) | 30.3 | 3.85 (0.95) | 71.3 | < 0.001 |
Naloxone | 72 | 2.89 (1.10) | 32.7 | 3.74 (1.08) | 63.3 | < 0.001 |
Naltrexone | 73 | 2.16 (1.01) | 7.3 | 3.07 (1.27) | 38.8 | 0.002 |
Acamprosate | 72 | 2.64 (1.14) | 25.7 | 3.38 (1.09) | 55.1 | < 0.001 |
Disulfiram | 83 | 3.07 (1.14) | 41.6 | 3.96 (1.03) | 76.3 | < 0.001 |
Methadone | 71 | 3.77 (1.21) | 61.5 | 4.21 (0.89) | 81.0 | < 0.001 |
Statement: Please choose the extent to which you disagree or agree with the following statement: | ||||||
I am confident in my skills to identify patients who may have a substance use disorder | 82 | 3.01 (1.12) | 33.6 | 3.66 (1.08) | 59.6 | < 0.001 |
I am confident discussing pharmacological alternatives to opioids with patients | 84 | 3.76 (0.87) | 64.7 | 4.30 (0.66) | 86.7 | < 0.001 |
I am confident discussing non-pharmacological alternatives to opioids with patients | 73 | 3.37 (1.23) | 47.7 | 3.89 (1.04) | 65.5 | 0.003 |
I am confident having difficult conversations with patients regarding their request for an opioid prescription | 87 | 3.71 (0,99) | 58.4 | 4.10 (0.88) | 79.2 | < 0.001 |
I am confident in my skills to identify patients who may have a substance use disorder | 82 | 3.01 (1.12) | 33.6 | 3.66 (1.08) | 59.6 | < 0.001 |